PhD Candidate
King's College London and National University of Singapore, United Kingdom
Mona Belaid is completing a Joint PhD in Pharmaceutical Science at King's College London and National University of Singapore. Her project focuses on exploring the potential of mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) as novel therapeutics for inflammatory bowel disease, with a focus on oral delivery. After her PhD, Mona wants to continue working in research to advance scientific knowledge and medical innovation. Her interests include nanomedicine, drug delivery, regenerative medicine and aging research.
https://www.linkedin.com/in/mona-belaid/
Disclosure information not submitted.
Oral delivery of MSC-EVs as a novel approach to treat inflammatory bowel disease
Thursday, July 17, 2025
11:05 AM - 11:16 AM EDT